|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.90 SEK | +27.79% |
|
+2.76% | -34.07% |
| 06-18 | Edison Maintains Its Valuation for Synact Pharma After Trial Results | FW |
| 06-18 | Synact Pharma no longer has any publicly disclosed short seller | FW |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 13 | 17.42 | 17.42 |
| Spread/Res. | +14.62% | -14.47% | -14.47% |
| Spread/Supp. | +39.77% | +39.77% | +42.04% |
| Support | 10.66 | 10.66 | 10.49 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SYNACT Stock
- Charts SynAct Pharma AB
Select your edition
All financial news and data tailored to specific country editions
